Page last updated: 2024-10-18

dihydroxyacetone phosphate and Leishmaniasis, Cutaneous

dihydroxyacetone phosphate has been researched along with Leishmaniasis, Cutaneous in 1 studies

Dihydroxyacetone Phosphate: An important intermediate in lipid biosynthesis and in glycolysis.
dihydroxyacetone phosphate : A member of the class of glycerone phosphates that consists of glycerone bearing a single phospho substituent.

Leishmaniasis, Cutaneous: An endemic disease that is characterized by the development of single or multiple localized lesions on exposed areas of skin that typically ulcerate. The disease has been divided into Old and New World forms. Old World leishmaniasis is separated into three distinct types according to epidemiology and clinical manifestations and is caused by species of the L. tropica and L. aethiopica complexes as well as by species of the L. major genus. New World leishmaniasis, also called American leishmaniasis, occurs in South and Central America and is caused by species of the L. mexicana or L. braziliensis complexes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zufferey, R1
Mamoun, CB1

Other Studies

1 other study available for dihydroxyacetone phosphate and Leishmaniasis, Cutaneous

ArticleYear
The initial step of glycerolipid metabolism in Leishmania major promastigotes involves a single glycerol-3-phosphate acyltransferase enzyme important for the synthesis of triacylglycerol but not essential for virulence.
    Molecular microbiology, 2005, Volume: 56, Issue:3

    Topics: Amino Acid Sequence; Animals; Dihydroxyacetone Phosphate; Genes, Protozoan; Glycerides; Glycerol-3-P

2005